Invesaro

Stocks Health care ICLR

NASDAQ · Health care

Icon PLC (ICLR)

Icon PLC reported revenue of $8.3B in fiscal 2025, up 0.8% from a year earlier. Net income was $229.3M, a net margin of 2.8%. Operating cash flow minus capital spending left $862M of free cash flow in fiscal 2025. At December 31, 2025 it held $647.3M in cash against $2.9B of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on May 27, 2026.

Price
$172.33
-0.90% on the day · September 25, 2026
52-week range $66.57 to $203.91
Market cap
$13.2B
Revenue (FY2025)
$8.3B
+0.8% year on year
Net margin
2.8%

What Icon PLC does

Icon PLC is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NASDAQ under the ticker ICLR.

Revenue and profit by year

Revenue
FY18: $2.6B $2.6B FY18FY19: $2.8B $2.8B FY19FY20: $2.8B $2.8B FY20FY21: $5.5B $5.5B FY21FY22: $7.7B $7.7B FY22FY23: $8.1B $8.1B FY23FY24: $8.2B $8.2B FY24FY25: $8.3B $8.3B FY25
Net income
FY18: $322.7M $322.7M FY18FY19: $374M $374M FY19FY20: $332.3M $332.3M FY20FY21: $153.2M $153.2M FY21FY22: $505.3M $505.3M FY22FY23: $554.2M $554.2M FY23FY24: $739.1M $739.1M FY24FY25: $229.3M $229.3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$8.3B$442.8M$229.3M$2.90$862M
2024$8.2B$1B$739.1M$8.90$1.1B
2023$8.1B$904.7M$554.2M$6.70$1B
2022$7.7B$795.2M$505.3M$5.55$421.2M
2021$5.5B$378.5M$153.2M$2.04$735.4M
2020$2.8B$391.5M$332.3M$5.57$527.2M

Latest SEC filings

What Icon PLC has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 9, 2026
    Foreign issuer update 6-K
  2. August 20, 2026
    Foreign issuer update 6-K
  3. August 18, 2026
    Foreign issuer update 6-K
  4. August 6, 2026
    Passive stake changed SCHEDULE 13G/A
  5. August 6, 2026
    Foreign issuer update 6-K
  6. July 31, 2026
    Foreign issuer update 6-K
  7. July 30, 2026
    Foreign issuer update 6-K
  8. July 29, 2026
    Foreign issuer update 6-K
  9. July 22, 2026
    Foreign issuer update 6-K
  10. June 26, 2026
    Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 18, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about ICLR

What does Icon PLC do?

Icon PLC is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NASDAQ under the ticker ICLR.

Is Icon PLC profitable?

Yes. In fiscal 2025 it reported net income of $229.3M on revenue of $8.3B, a net margin of 2.8%.

How much revenue does Icon PLC make?

In fiscal 2025 Icon PLC reported revenue of $8.3B. That is 0.8% more than a year earlier.

When did Icon PLC last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on May 27, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the insider trade from September 18, 2026.

Similar companies

IQV
Iqvia Holdings Inc.
INCY
Incyte Corp
CRL
Charles River Laboratories International, Inc.
MEDP
Medpace Holdings, Inc.
NOTVQ
Inotiv, Inc.
NRC
Nrc Health

Follow ICLR

Get an email when Icon PLC files with the SEC: results, executive changes, material agreements and annual reports.

Follow ICLR: get an email when it files

Where the numbers come from

Financial figures are the values Icon PLC tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.